As expected, FHVH3/VH1 CAR-T cells exhibited stronger CD5 antigen-specific degranulation and killing ability than either H65, FHVH1, or FHVH3 CAR-T cells, especially for tumor cells with moderate expression of CD5 antigen. The gene discussed is CD5; the disease is neoplasm.